PMID: 799990Jan 1, 1976

Nitrazepam and temazepam: a comparative trial of two hypnotics

The Journal of International Medical Research
R G Priest, Z A Rizvi

Abstract

A specially designed sleep questionnaire was used to assess the performance of the two hypnotic drugs. Psychiatric patients were given 5 mg nitrazepam or 10 mg temazepam in identical capsules, and were allowed more if necessary. A double-blind cross-over design was used. We found that 5-2 mg nitrazepam showed few differences from 13-2 mg temezepam. The two regimes produced fairly similar reports on patient satisfaction, quality of sleep, number of awakenings, depth of sleep and other variables. Patients on nitrazepam were a little more clear-headed in the morning, though they tended to wake later, sleep longer, and take more sleep over the 24-hour period. No toxicity was found with either drug over the 434 patient days of administration. In view of the advantages of the benzodiazepine drugs over their predecessors, we feel that it is worth exploring further the use of temazepam as a sleep inducing drug.

References

May 1, 1973·The Journal of Pharmacy and Pharmacology·G T Hajos, S Garattini
Aug 22, 1973·Psychopharmacologia·S R Allen, I Oswald
Oct 1, 1970·European Journal of Pharmacology·B Silvestrini, E Quadri
Aug 1, 1973·European Journal of Pharmacology·A BizziS Garattini
Feb 20, 1961·Psychopharmacologia·L E HOLLISTERR O DEGAN
Nov 6, 1965·British Medical Journal·I Oswald, R G Priest

Citations

Jan 1, 1982·Current Medical Research and Opinion·D Van Steenis
Sep 1, 1983·British Journal of Clinical Pharmacology·I C McManusR G Priest
Apr 27, 2002·Journal of Clinical Pharmacy and Therapeutics·M Ramesh, G Roberts
Mar 25, 2017·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Matteo GiordaniLaura Valentini
Jul 1, 1981·Pharmacotherapy·M M Mitler
Jan 1, 1979·The Journal of International Medical Research·C A Moon, M Schiller
Sep 1, 1982·Drug Intelligence & Clinical Pharmacy·J C McElnayB Alexander

Related Concepts

Benzodiazepines
Clinical Trials
Valium
Drug Evaluation
Sedatives
Imeson
Sleep, Slow-Wave

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Synthetic Genetic Array Analysis

Synthetic genetic arrays allow the systematic examination of genetic interactions. Here is the latest research focusing on synthetic genetic arrays and their analyses.

Congenital Hyperinsulinism

Congenital hyperinsulinism is caused by genetic mutations resulting in excess insulin secretion from beta cells of the pancreas. Here is the latest research.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Epigenetic Memory

Epigenetic memory refers to the heritable genetic changes that are not explained by the DNA sequence. Find the latest research on epigenetic memory here.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Femoral Neoplasms

Femoral Neoplasms are bone tumors that arise in the femur. Discover the latest research on femoral neoplasms here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.